Literature DB >> 28768258

Septic Complications after Resection for Middle or Low Rectal Cancer: Role of Gut Barrier Function and Inflammatory Serum Markers.

Mario Schietroma1, Beatrice Pessia, Sara Colozzi, Francesco Carlei, Marco Clementi, Gianfranco Amicucci, Stefano Guadagni.   

Abstract

BACKGROUND: The focus of this study was to understand the relationship between the failure of gut barrier function, inflammatory markers and septic complications after resection for extraperitoneal rectal cancer.
METHODS: One hundred seven patients were enrolled into this prospective observational study and underwent open colorectal resection for extraperitoneal cancer. All patients underwent an assessment of intestinal permeability (L/M ratio), endotoxemia, interleukin-1β (IL-1β), interleukin-6 (IL-6), C-reactive protein (CRP) and elastase levels before surgery and on postoperative days 1, 3, and 7.
RESULTS: Septic complications developed in 23.3% of patients. There were no significant differences in preoperative L/M ratio, endotoxine, CRP, interleukin-1 (IL-1), IL-6, and elastase levels between septic and non-septic groups. All patients showed a significant increase in intestinal permeability, endotoxemia, IL-1, IL-6, CRP, and elastase on the first postoperative day. At postoperative day 7, the septic group continued to demonstrate an increase in intestinal permeability, endotoxemia and elastase and significant difference was observed between the 2 groups (p < 0.05), whereas there was no significant difference in IL-1, IL-6, and CRP levels.
CONCLUSION: The pattern of change in the postoperative period of intestinal permeability, systemic endotoxemia and elastase concentration is significantly higher in patients in whom sepsis develops, while the concentration of IL-1β, IL-6, and CRP does not permit to distinguish infection from inflammation.
© 2017 S. Karger AG, Basel.

Entities:  

Keywords:  Extraperitoneal rectal cancer; Gut barrier function; Inflammatory serum markers; Rectal surgery

Mesh:

Substances:

Year:  2017        PMID: 28768258     DOI: 10.1159/000475847

Source DB:  PubMed          Journal:  Dig Surg        ISSN: 0253-4886            Impact factor:   2.588


  4 in total

Review 1.  Mid- and low-rectal cancer: laparoscopic vs open treatment-short- and long-term results. Meta-analysis of randomized controlled trials.

Authors:  Mario Schietroma; Lucia Romano; Adriana Ionelia Apostol; Silvia Vada; Stefano Necozione; Francesco Carlei; Antonio Giuliani
Journal:  Int J Colorectal Dis       Date:  2021-10-29       Impact factor: 2.571

2.  Colostomy Reversal following Hartmann's Procedure: The Importance of Timing in Short- and Long-Term Complications: A Retrospective Multicentric Study.

Authors:  Marco Clementi; Renato Pietroletti; Filippo Carletti; Federico Sista; Antonella Grasso; Fabiana Fiasca; Sonia Cappelli; Andrea Balla; Vinicio Rizza; Andrea Ciarrocchi; Stefano Guadagni
Journal:  J Clin Med       Date:  2022-07-28       Impact factor: 4.964

3.  IL-6, TNF-α and IL-12p70 levels in patients with colorectal cancer and their predictive value in anti-vascular therapy.

Authors:  Jingxian Zheng; Xiaojie Wang; Jiami Yu; Zhouwei Zhan; Zengqing Guo
Journal:  Front Oncol       Date:  2022-09-26       Impact factor: 5.738

4.  Association of Habitual Preoperative Dietary Fiber Intake With Complications After Colorectal Cancer Surgery.

Authors:  Dieuwertje E Kok; Melissa N N Arron; Tess Huibregtse; Flip M Kruyt; Dirk Jan Bac; Henk K van Halteren; Ewout A Kouwenhoven; Evertine Wesselink; Renate M Winkels; Moniek van Zutphen; Fränzel J B van Duijnhoven; Johannes H W de Wilt; Ellen Kampman
Journal:  JAMA Surg       Date:  2021-06-16       Impact factor: 16.681

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.